Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection

NCT02355951 is registered in ClinicalTrials.gov with Transgene as lead sponsor.

NCT NCT02355951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02355951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection
Lead sponsor
Transgene
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2014
Completion date
February 29, 2016
Enrollment
166 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b